How to Reconstitute SS-31? (Step-by-Step Protocol)

How to Reconstitute SS-31? (Step-by-Step Protocol)

Most peptide protocols fail at the storage stage, not the injection stage. A single temperature excursion above 8°C during shipping or at home can denature the protein structure entirely, turning an effective compound into an effective saline injection. The gap between doing it right and doing it wrong comes down to three things most guides never mention: water-to-powder contact angle, vial pressure equilibration, and the 28-day viability window that starts the moment you reconstitute SS-31.

We've guided hundreds of research teams through this exact process. The mistakes that ruin peptide viability happen before the first draw. Not after.

How do you properly reconstitute SS-31 (elamipretide) for research use?

Reconstitute SS-31 by injecting 2ml bacteriostatic water slowly down the inside wall of the vial containing lyophilised powder. Never inject directly onto the powder. Allow the solution to dissolve passively without shaking, then refrigerate at 2–8°C and use within 28 days. The reconstituted peptide must remain sterile and temperature-controlled throughout its viable lifespan.

Yes, you can reconstitute SS-31 at home or in a lab setting. But the protocol requires more than sterile water and a syringe. The mitochondrial-targeted tetrapeptide SS-31 (elamipretide) is structured with aromatic-cationic residues that allow it to concentrate in the inner mitochondrial membrane, where it stabilises cardiolipin and reduces reactive oxygen species production. That mechanism is conditional on maintaining the peptide's exact amino acid sequencing. Which begins degrading the moment reconstitution occurs improperly or storage conditions deviate. This article covers the exact reconstitution procedure, the biological reasoning behind each step, and what preparation mistakes negate SS-31's mitochondrial-targeting efficacy entirely.

Step 1: Verify Lyophilised SS-31 Storage Conditions Before Opening the Vial

Before you reconstitute SS-31, confirm the lyophilised powder was stored at −20°C from the moment of synthesis until you're ready to use it. Peptides in lyophilised form are shelf-stable at freezer temperatures for 12–24 months, but any temperature excursion above −10°C starts a degradation clock you cannot reverse. Check the vial for condensation, discolouration, or clumping. Any of these signals moisture intrusion or improper storage, both of which compromise amino acid integrity before you've added a single drop of bacteriostatic water.

SS-31 (Tyr-D-Arg-Phe-Lys-NH2) is a synthetic tetrapeptide with a molecular weight of approximately 640 Da, making it small enough to cross mitochondrial membranes but large enough that structural precision matters. The D-arginine residue at position 2 is what gives SS-31 its resistance to peptidase degradation. But that same residue is vulnerable to racemisation if the lyophilised powder is exposed to humidity or heat. In our experience working with research-grade peptides, vials shipped without adequate cold chain packaging show measurably lower potency even when the powder appears visually intact.

Remove the vial from freezer storage and allow it to reach room temperature passively. Never microwave, heat, or place under warm water to accelerate the process. Condensation forming inside a cold vial the moment you open it is enough to introduce moisture contamination before reconstitution begins. Let the sealed vial sit at ambient temperature (20–25°C) for 10–15 minutes, then wipe the rubber stopper with a sterile alcohol pad before inserting a needle. If you're working with SS-31 Elamipretide sourced from Real Peptides, every batch is synthesised with exact amino-acid sequencing and third-party verified for purity. But even high-purity peptides degrade if handled improperly at the reconstitution stage.

Step 2: Prepare Bacteriostatic Water and Sterile Equipment in a Contamination-Free Environment

To reconstitute SS-31, you'll need bacteriostatic water (0.9% benzyl alcohol), a sterile syringe (1ml or 3ml), and an alcohol prep pad. Never use tap water, distilled water, or saline. Bacteriostatic water is formulated specifically to inhibit bacterial growth in multi-dose vials, extending the viable use window to 28 days post-reconstitution. Standard sterile water has no preservative, meaning contamination risk increases every time you puncture the stopper to draw a dose.

Draw 2ml of bacteriostatic water into a sterile syringe. For a standard 5mg vial of SS-31, this produces a final concentration of 2.5mg/ml. A common research dose that allows for precise volumetric dosing with insulin syringes. If your protocol requires a different concentration, adjust the volume of bacteriostatic water accordingly: 1ml yields 5mg/ml, while 2.5ml yields 2mg/ml. Write the reconstitution date and final concentration on the vial label immediately. Once multiple vials are in your refrigerator, visual identification becomes unreliable.

Work in a clean, low-traffic area. You don't need a sterile laminar flow hood for peptide reconstitution, but you do need to minimise airborne particulate contamination. Wipe down your work surface with 70% isopropyl alcohol, lay out all materials within arm's reach, and avoid touching the needle or syringe plunger with bare hands. The biggest mistake people make when reconstituting peptides isn't contamination. It's injecting air into the vial while drawing the solution. The resulting pressure differential pulls contaminants back through the needle on every subsequent draw.

If you're managing multiple research peptides. BPC-157, Thymosin Alpha-1, or Epithalon. Apply the same reconstitution protocol to each. Peptide structure varies, but the principles of sterile technique and controlled reconstitution remain constant across all research-grade compounds.

Step 3: Inject Bacteriostatic Water Slowly Down the Inside Vial Wall to Reconstitute SS-31

Insert the needle through the rubber stopper at a 45-degree angle, positioning the tip against the inside glass wall of the vial. Not aimed at the lyophilised powder cake at the bottom. Inject the bacteriostatic water slowly, allowing it to run down the vial wall and dissolve the powder passively through diffusion. This is the single most critical step: direct injection onto the powder creates foam, denatures surface-layer peptides, and reduces overall potency by 10–20% depending on injection force.

The reconstitution process should take 20–30 seconds for a 2ml injection. If you inject too quickly, you'll introduce air bubbles that are nearly impossible to remove without shaking. And shaking lyophilised peptides is one of the fastest ways to denature them. SS-31's mitochondrial-targeting mechanism depends on maintaining the exact spatial arrangement of its four amino acids; mechanical agitation disrupts hydrogen bonding and can cause aggregation, rendering the peptide biologically inactive even though it remains visually clear.

Once the bacteriostatic water is fully injected, remove the needle and allow the vial to sit undisturbed at room temperature for 3–5 minutes. The powder will dissolve on its own. No swirling, no shaking, no tapping required. If small particulates remain after five minutes, gently roll the vial between your palms (do not shake) until the solution is uniformly clear. A properly reconstituted SS-31 solution is colourless to pale yellow and completely transparent. Cloudiness, precipitate, or visible particles indicate contamination or degraded peptide. Discard the vial and start over.

Real Peptides produces every peptide through small-batch synthesis with USP-grade purity standards, but even pharmaceutical-grade compounds lose efficacy if reconstitution technique introduces structural damage. The process matters as much as the product.

How to Reconstitute SS-31: Concentration Comparison

Different reconstitution volumes produce different final concentrations, which directly affect dosing precision and injection volume per administration. The table below shows standard bacteriostatic water volumes, resulting SS-31 concentrations, and typical use cases for each.

Choose your reconstitution volume based on your dosing protocol and syringe precision. Insulin syringes (0.3ml–1ml) marked in 0.01ml increments allow for accurate measurement at concentrations between 2–5mg/ml. Larger volumes (5ml) require 3ml syringes with coarser gradation, which increases measurement error unless you're using calibrated pipettes.

Key Takeaways

• Reconstitute SS-31 by injecting bacteriostatic water slowly down the vial wall. Never directly onto the lyophilised powder, which causes foaming and denatures surface peptides.
• Store lyophilised SS-31 at −20°C before reconstitution; once reconstituted, refrigerate at 2–8°C and use within 28 days to maintain mitochondrial-targeting bioactivity.
• A standard 5mg vial reconstituted with 2ml bacteriostatic water yields 2.5mg/ml concentration. The most common research dose for volumetric precision.
• SS-31 (elamipretide) is a mitochondrial-targeted tetrapeptide that stabilises cardiolipin in the inner mitochondrial membrane, reducing reactive oxygen species production in models of ischaemia-reperfusion injury and heart failure.
• Temperature excursions above 8°C after reconstitution cause irreversible protein denaturation. Even brief exposure during shipping or storage renders the peptide inactive.
• Never shake reconstituted peptides. Allow passive diffusion to dissolve the powder, then roll gently if particulates remain after five minutes.

What If: SS-31 Reconstitution Scenarios

What If the Lyophilised Powder Looks Clumped or Discoloured Before Reconstitution?

Discard the vial. Do not attempt to reconstitute SS-31 if the powder shows clumping, yellowing, or moisture. Lyophilised peptides are hygroscopic, meaning they absorb ambient moisture if the vial seal is compromised. Once moisture contacts the powder before controlled reconstitution, peptide degradation accelerates and you cannot reverse it by adding bacteriostatic water. Clumping indicates the peptide has already begun breaking down; the amino acid sequence may be partially hydrolysed, which eliminates SS-31's mitochondrial selectivity.

What If I Accidentally Inject Bacteriostatic Water Directly Onto the Powder?

The peptide is still usable, but expect 10–15% potency loss due to surface denaturation caused by direct mechanical force. If foam forms, let the vial sit undisturbed for 10 minutes to allow bubbles to dissipate naturally. Do not shake or agitate further. Document the error and consider adjusting your dosing protocol upward by 10–15% to compensate for reduced bioavailability, or discard the vial if your research protocol requires exact potency verification.

What If the Reconstituted Solution Remains Cloudy After 10 Minutes?

Cloudiness indicates particulate contamination, peptide aggregation, or incomplete dissolution. None of which are safe to inject. Roll the vial gently for 30 seconds; if clarity does not improve, discard the solution. Aggregated peptides lose their three-dimensional structure and cannot bind to mitochondrial membranes as intended. In our experience reviewing preparation errors across research protocols, cloudiness most often results from using expired bacteriostatic water or reconstituting a vial that was inadequately lyophilised during manufacturing.

What If I Need to Reconstitute SS-31 But Don't Have Bacteriostatic Water?

Use sterile water for injection as a single-use alternative, but you must discard any unused portion within 24 hours. Sterile water lacks the benzyl alcohol preservative that inhibits bacterial growth in multi-dose vials, meaning contamination risk compounds with each needle puncture. If your protocol requires multiple doses over several days, bacteriostatic water is non-negotiable. Sterile water is a temporary substitute only when immediate reconstitution is required and no alternative is available.

The Clinical Truth About How to Reconstitute SS-31

Here's the honest answer: most peptide degradation happens during reconstitution and storage. Not during synthesis or shipping. You can source pharmaceutical-grade SS-31 from a top-tier supplier, but if you inject the bacteriostatic water too quickly, shake the vial, or store the reconstituted peptide at room temperature for even a few hours, you've eliminated the compound's efficacy before the first dose. The mechanism is unforgiving. SS-31's mitochondrial selectivity depends on maintaining exact peptide folding, and once that structure is disrupted, no amount of proper dosing or injection technique will restore it.

The 28-day post-reconstitution window is not arbitrary. Benzyl alcohol in bacteriostatic water inhibits bacterial contamination but does not prevent peptide hydrolysis. The breakdown of peptide bonds in aqueous solution. SS-31 is relatively stable compared to longer peptides like BPC-157 or Thymosin Beta-4, but even tetrapeptides experience measurable potency loss beyond four weeks in solution. Research published in the Journal of Pharmaceutical Sciences shows that most synthetic peptides lose 15–25% bioactivity after 30 days at 4°C in bacteriostatic water. And that timeline accelerates significantly if the solution is stored at temperatures above 8°C.

The bottom line: reconstitute SS-31 with the same precision you'd apply to dose preparation. The steps are simple, but the margin for error is small. Every protocol decision. Water volume, injection angle, storage temperature. Either preserves or destroys the peptide's mitochondrial-targeting function.

Reconstituting research peptides correctly is the foundation of reproducible results. Whether you're working with SS-31 Elamipretide for mitochondrial function studies, NAD+ for cellular metabolism research, or Epithalon for telomerase activation models, the reconstitution protocol remains the same: slow injection, passive dissolution, refrigerated storage, and adherence to the 28-day viability window. The compound's potential is written in its amino acid sequence. Your job is to preserve that sequence from vial to injection.

If the reconstituted solution sits in your refrigerator for 35 days, it's not 'probably still good'. It's measurably degraded, and using it introduces uncontrolled variables into your research. Mark the reconstitution date on every vial, refrigerate immediately, and discard any solution that exceeds the 28-day threshold. Proper reconstitution technique ensures that what you inject matches what was synthesised. Anything less is guesswork.